Retour
Fourchette du Jour
11,04 €
12,01 €
Fourchette 52 Semaines
6,92 €
18,69 €
Volume
1 230 502
Moyenne 50J / 200J
12,31 €
/
11,72 €
Clôture Précédente
12,05 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,5 | 0,4 |
| P/B | 1,4 | 2,9 |
| ROE % | -14,0 | 3,9 |
| Net Margin % | -73,2 | 3,8 |
| Rev Growth 5Y % | -17,8 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
28,75 €
+141.8%
Low: 18,00 €
High: 42,00 €
BPA Prévisionnel
-2,88 €
CA Est.
120 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,04 €
0,00 € – 0,11 €
|
530 M | 3 |
| FY2029 |
-1,46 €
-3,72 € – 0,10 €
|
270 M | 3 |
| FY2028 |
-2,70 €
-4,08 € – -0,75 €
|
170 M | 9 |
Points Clés
Revenue declined -17,80% annually over 5 years
Debt/Equity of 0,30 — conservative balance sheet
Negative free cash flow of -138,27M
PEG of 0,19 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 31,45%
Capital efficient — spends only 2,51% of revenue on capex
Croissance
Revenue Growth (5Y)
-17,80%
Revenue (1Y)13,65%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-14,00%
ROIC-16,17%
Net Margin-73,20%
Op. Margin-141,35%
Sécurité
Debt / Equity
0,30
Current Ratio6,25
Interest Coverage-5,56
Valorisation
P/E Ratio
-9,49
P/B Ratio1,37
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,65% | Revenue Growth (3Y) | -15,20% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -17,80% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 125,58M | Net Income (TTM) | -91,92M |
| ROE | -14,00% | ROA | -10,50% |
| Gross Margin | 91,63% | Operating Margin | -141,35% |
| Net Margin | -73,20% | Free Cash Flow (TTM) | -138,27M |
| ROIC | -16,17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,30 | Current Ratio | 6,25 |
| Interest Coverage | -5,56 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,49 | P/B Ratio | 1,37 |
| P/S Ratio | 6,94 | PEG Ratio | 0,19 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 872,00M | Enterprise Value | 1,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 125,58M | 110,49M | 174,62M | 164,58M | 275,11M |
| Net Income | -91,92M | -232,62M | -133,13M | -55,18M | 82,63M |
| EPS (Diluted) | -1,24 | -3,58 | -2,08 | -0,93 | 1,37 |
| Gross Profit | 115,06M | 110,49M | 174,62M | 164,58M | 275,11M |
| Operating Income | -177,50M | -178,41M | -132,36M | -82,47M | 43,77M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 875,50M | 951,95M | 952,69M | 846,27M | 838,21M |
| Total Liabilities | 239,91M | 277,92M | 283,56M | 118,77M | 104,71M |
| Shareholders' Equity | 635,59M | 677,61M | 668,80M | 727,50M | 733,50M |
| Total Debt | 187,75M | 231,95M | 83,43M | 59,63M | 33,97M |
| Cash & Equivalents | 54,07M | 40,88M | 53,79M | 53,94M | 143,48M |
| Current Assets | 599,82M | 577,60M | 623,16M | 675,34M | 424,37M |
| Current Liabilities | 95,91M | 87,43M | 84,71M | 63,84M | 70,74M |